{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:32:52Z","timestamp":1793914372534,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41401-022-00907-5","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:04:08Z","timestamp":1651658648000},"page":"2917-2928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells"],"prefix":"10.1038","volume":"43","author":[{"given":"Hao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"907_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"907_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113\u201321.","journal-title":"Gastroenterology."},{"key":"907_CR3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 2016;24:848\u201362.","journal-title":"Cell Metab"},{"key":"907_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/hep.30294","volume":"69","author":"S Lefere","year":"2019","unstructured":"Lefere S, Van de Velde F, Hoorens A, Raevens S, Van Campenhout S, Vandierendonck A, et al. Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease. Hepatology. 2019;69:1087\u2013104.","journal-title":"Hepatology."},{"key":"907_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","volume":"130","author":"CP Day","year":"2006","unstructured":"Day CP. From fat to inflammation. Gastroenterology. 2006;130:207\u201310.","journal-title":"Gastroenterology."},{"key":"907_CR6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1055\/s-0028-1091981","volume":"28","author":"J Jou","year":"2008","unstructured":"Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28:370\u20139.","journal-title":"Semin Liver Dis"},{"key":"907_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pathophys.2008.05.001","volume":"15","author":"C Bertolani","year":"2008","unstructured":"Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology. 2008;15:91\u2013101.","journal-title":"Pathophysiology."},{"key":"907_CR8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176:1248\u201364.","journal-title":"Cell."},{"key":"907_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","volume":"1","author":"C Bocca","year":"2015","unstructured":"Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and fibrogenesis in chronic liver diseases. Cell Mol Gastroenterol Hepatol. 2015;1:477\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"907_CR10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","volume":"35","author":"C Corpechot","year":"2002","unstructured":"Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology. 2002;35:1010\u201321.","journal-title":"Hepatology."},{"key":"907_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/cas.13902","volume":"110","author":"K Miura","year":"2019","unstructured":"Miura K, Ohnishi H, Morimoto N, Minami S, Ishioka M, Watanabe S, et al. Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet. Cancer Sci. 2019;110:771\u201383.","journal-title":"Cancer Sci"},{"key":"907_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/hep.20590","volume":"41","author":"N Beraza","year":"2005","unstructured":"Beraza N, Marques JM, Martinez-Anso E, Iniguez M, Prieto J, Bustos M. Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration. Hepatology. 2005;41:460\u20139.","journal-title":"Hepatology."},{"key":"907_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L.","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182\u2013236.","journal-title":"J Hepatol"},{"key":"907_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.arcmed.2010.12.001","volume":"42","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Ozdogan O, Celikel CA, et al. Circulating levels of vascular endothelial growth factor A and its soluble receptor in patients with biopsy-proven nonalcoholic fatty liver disease. Arch Med Res. 2011;42:38\u201343.","journal-title":"Arch Med Res"},{"key":"907_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cyto.2012.05.001","volume":"59","author":"S Coulon","year":"2012","unstructured":"Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, et al. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine. 2012;59:442\u20139.","journal-title":"Cytokine."},{"key":"907_CR16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MEG.0b013e3283229b40","volume":"21","author":"G Tarantino","year":"2009","unstructured":"Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21:504\u201311.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"907_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/hep.29518","volume":"67","author":"B Wang","year":"2018","unstructured":"Wang B, Fu J, Yu T, Xu A, Qin W, Yang Z, et al. Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice. Hepatology. 2018;67:623\u201335.","journal-title":"Hepatology."},{"key":"907_CR18","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/nprot.2016.097","volume":"11","author":"L Broutier","year":"2016","unstructured":"Broutier L, Andersson-Rolf A, Hindley CJ, Boj SF, Clevers H, Koo BK, et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc. 2016;11:1724\u201343.","journal-title":"Nat Protoc"},{"key":"907_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol. 2018;69:385\u201395.","journal-title":"J Hepatol"},{"key":"907_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2006.03.017","volume":"45","author":"M Kornek","year":"2006","unstructured":"Kornek M, Raskopf E, Guetgemann I, Ocker M, Gerceker S, Gonzalez-Carmona MA, et al. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H\/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1. J Hepatol. 2006;45:370\u20136.","journal-title":"J Hepatol"},{"key":"907_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","volume":"65","author":"SM Francque","year":"2016","unstructured":"Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J Hepatol. 2016;65:425\u201343.","journal-title":"J Hepatol"},{"key":"907_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531:253\u20137.","journal-title":"Nature"},{"key":"907_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"key":"907_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73:4\u201313.","journal-title":"Hepatology."},{"key":"907_CR25","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jfma.2020.05.027","volume":"119","author":"HJ Su","year":"2020","unstructured":"Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, et al. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. J Formos Med Assoc. 2020;119:1476\u201382.","journal-title":"J Formos Med Assoc"},{"key":"907_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/ijms19051269","volume":"19","author":"SL Barratt","year":"2018","unstructured":"Barratt SL, Flower VA, Pauling JD, Millar AB. VEGF (vascular endothelial growth factor) and fibrotic lung disease. Int J Mol Sci. 2018;19:1269.","journal-title":"Int J Mol Sci."},{"key":"907_CR27","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/cancers12113145","volume":"12","author":"P Ntellas","year":"2020","unstructured":"Ntellas P, Mavroeidis L, Gkoura S, Gazouli I, Amylidi AL, Papadaki A, et al. Old player-new tricks: non angiogenic effects of the VEGF\/VEGFR pathway in cancer. Cancers. 2020;12:3145.","journal-title":"Cancers"},{"key":"907_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","volume":"146","author":"L Yang","year":"2014","unstructured":"Yang L, Kwon J, Popov Y, Gajdos GB, Ordog T, Brekken RA, et al. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology. 2014;146:1339\u201350.e1.","journal-title":"Gastroenterology"},{"key":"907_CR29","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"907_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2019.09.012","volume":"72","author":"D Caballero-Diaz","year":"2020","unstructured":"Caballero-Diaz D, Bertran E, Penuelas-Haro I, Moreno-Caceres J, Malfettone A, Lopez-Luque J, et al. Clathrin switches transforming growth factor-beta role to pro-tumorigenic in liver cancer. J Hepatol. 2020;72:125\u201334.","journal-title":"J Hepatol"},{"key":"907_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jpi.12092","volume":"56","author":"R Ordonez","year":"2014","unstructured":"Ordonez R, Carbajo-Pescador S, Prieto-Dominguez N, Garcia-Palomo A, Gonzalez-Gallego J, Mauriz JL. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res. 2014;56:20\u201330.","journal-title":"J Pineal Res"},{"key":"907_CR32","doi-asserted-by":"crossref","unstructured":"Foglia B, Sutti S, Pedicini D, Cannito S, Bocca C, Maggiora M, et al. Oncostatin M, a profibrogenic mediator overexpressed in non-alcoholic fatty liver disease, stimulates migration of hepatic myofibroblasts. Cells. 2019;9:28.","DOI":"10.3390\/cells9010028"},{"key":"907_CR33","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","volume":"154","author":"K Du","year":"2018","unstructured":"Du K, Hyun J, Premont RT, Choi SS, Michelotti GA, Swiderska-Syn M, et al. Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells. Gastroenterology. 2018;154:1465\u201379.e13.","journal-title":"Gastroenterology."},{"key":"907_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00204-4","volume":"8","author":"K Zhang","year":"2017","unstructured":"Zhang K, Han X, Zhang Z, Zheng L, Hu Z, Yao Q, et al. The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFbeta and Notch pathways. Nat Commun. 2017;8:144.","journal-title":"Nat Commun"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00907-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00907-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00907-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:07:08Z","timestamp":1667261228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00907-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["907"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-00907-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study has been approved by the Research Ethics Committee of Eastern Hepatobiliary Surgery Hospital, and the informed consent has been obtained. All animal experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Second Military Medical University (Shanghai, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}